Posts by John B. Miller, MD
-
Non-invasive OCTA Imaging Biomarker Tied to Neovascular Glaucoma in Patients With Proliferative Diabetic Retinopathy
John B. Miller, MD, Edward S. Lu, MD, and colleagues found retinal ischemia on widefield swept-source optical coherence tomography angiography was associated with 13-fold increased odds of neovascular glaucoma, a vision-threatening complication in patients with proliferative diabetic retinopathy.
-
Review: Telemedicine for Diagnosis and Management of Age-Related Macular Degeneration
John B. Miller, MD, and Grayson W. Armstrong, MD, MPH, of the Mass Eye and Ear Department of Ophthalmology report that advances in telemedicine allow for remote screening for AMD, electronic consultations between comprehensive ophthalmologists and retina specialists, and home-based disease monitoring.
-
Widefield Swept-Source OCTA Predicts Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy
In a prospective study, John B. Miller, MD, of the Department of Ophthalmology, and colleagues observed that widefield swept-source optical coherence tomography angiography, independent of conventional imaging, helped detect signs of impending vitreous hemorrhage in patients with proliferative diabetic retinopathy.
-
Retinal Imaging Detects Biomarkers of Familial Alzheimer's Disease Years Before Symptoms
Mass General researchers were part of the first study to demonstrate the ability of optical coherence tomography to detect retinal biomarkers in carriers of the most common gene causing familial Alzheimer's disease.
Biography
Dr. Miller maintains an active research program in addition to his strong clinical retina practice. As a clinician scientist, his work focuses both on clinical research and the basic mechanisms of retinal disease through study in the laboratory. In the Ines and Frederick Yeatts Retina Research Laboratory at Mass Eye and Ear, he has explored the mechanisms of retinal toxicity of systemic medications. Ongoing work explores the pathogenesis of age-related macular degeneration, macular telangiectasia, macular hole, and drug retinal toxicities.
His clinical research includes age-related macular degeneration, traumatic macular holes, and macular telangiectasia. He maintains a particular focus on retinal imaging devices, including Swept Source OCT (investigational). With additional advances in retinal imaging, he hopes to provide earlier detection of disease or predisposing factors, better prognostic information, and disease maintenance.
Dr. Miller has received multiple investigator awards, including those from top subspecialty societies: the Retina Society and Macula Society.
He maintains a close association with the latest developments in both diagnostics and therapeutics through regular attendance at subspecialty meetings, including the Retina Society, the American Society of Retina Specialists (ASRS), Association of Research in Vision and Ophthalmology (ARVO), and the Vit Buckle Society (VBS). He serves on the education committee of the Vit Buckle Society, striving to improve the surgical techniques of others through collaboration.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
